Prospective, single-arm, multi-center registry study A total of 50 subjects with Type B aortic dissection who meet all inclusion and exclusion criteria will be included. Patients will be treated with TEVAR using conformable TAG endograft (Gore). Patients will be followed clinically for 12 months after the procedure. CT will be performed at 12 months.
Study Type
OBSERVATIONAL
Major adverse event
A composite of all-cause death, re-intervention, and aortic dilation \> 5 mm in maximal aortic diameter
Time frame: 12 months
Aortic remodeling
Change in maximal aorta, true lumen, and false lumen dimensions
Time frame: 12 months
Aorta-related complications
composite events of aortic rupture, stroke, spinal chord ischemia, retrograde dissection, endoleaks, aortic dilation \> 5mm in diameter
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.